Canada markets closed

Elite Pharmaceuticals, Inc. (ELTP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1298+0.0006 (+0.49%)
At close: 02:35PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
47,318
34,155
32,262
25,381
Cost of Revenue
25,638
17,561
17,467
13,514
Gross Profit
21,680
16,594
14,795
11,867
Operating Expenses
Research Development
7,591
6,200
4,051
5,113
Selling General and Administrative
5,794
5,162
4,478
3,336
Total Operating Expenses
14,714
12,625
9,725
9,763
Operating Income or Loss
6,966
3,969
5,071
2,105
Interest Expense
701.964
1,113
191.816
259.598
Total Other Income/Expenses Net
-8,674
1,122
1,425
2,299
Income Before Tax
-2,386
3,986
6,304
4,145
Income Tax Expense
-17,940
424.028
-1,736
-943.907
Income from Continuing Operations
15,554
3,562
8,898
5,088
Net Income
15,554
3,562
8,898
5,088
Net Income available to common shareholders
15,554
3,562
8,898
5,088
Basic EPS
0.02
0.00
0.01
0.01
Diluted EPS
0.02
0.00
0.01
0.00
Basic Average Shares
1,013,988
1,012,911
1,010,608
942,998
Diluted Average Shares
1,015,502
1,012,911
1,010,608
942,998